Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Non-Current Assets (2020 - 2024)

Immuneering has reported Non-Current Assets over the past 5 years, most recently at $13.3 million for Q3 2024.

  • Quarterly results put Non-Current Assets at $13.3 million for Q3 2024, changed 0.0% from a year ago — trailing twelve months through Sep 2024 was $53.7 million (changed 0.06% YoY), and the annual figure for FY2023 was $13.5 million, down 0.88%.
  • Non-Current Assets for Q3 2024 was $13.3 million at Immuneering, down from $13.4 million in the prior quarter.
  • Over the last five years, Non-Current Assets for IMRX hit a ceiling of $14.4 million in Q4 2021 and a floor of $691799.0 in Q4 2020.
  • Median Non-Current Assets over the past 5 years was $13.4 million (2023), compared with a mean of $11.6 million.
  • Biggest five-year swings in Non-Current Assets: surged 1977.31% in 2021 and later decreased 5.22% in 2022.
  • Immuneering's Non-Current Assets stood at $691799.0 in 2020, then surged by 1977.31% to $14.4 million in 2021, then dropped by 5.22% to $13.6 million in 2022, then dropped by 0.88% to $13.5 million in 2023, then dropped by 1.51% to $13.3 million in 2024.
  • The last three reported values for Non-Current Assets were $13.3 million (Q3 2024), $13.4 million (Q2 2024), and $13.5 million (Q1 2024) per Business Quant data.